The Absurd Markup of Over 300% on Average For Chemotherapy Drugs

Executive Summary

  • Cancer centers very significantly mark up chemotherapy drugs.
  • This article covers this topic from several dimensions.


If one looks at the normal drug market, one sees corruption in that the pharma companies create financial incentives for MDs to prescribe on-patent drugs for which there are better generic alternatives. However, for most drugs, MDs are not allowed to markup drugs. Yet this rule does not apply to chemotherapy drugs.

Wait One Second...

Why is The Article Not Viewable?

You are seeing this text instead of the article because of two potential reasons.

Reason #1: You are a Subscriber but Not Signed In

You can sign in by simply sending yourself a link to the email you signed in with by going here.

It's as easy as 1,2,3.  

You can read any article on the site as soon as you sign in.

Reason #2: You Are Not Yet Subscribed to the Site

This is a subscription site. That is how we pay for the research we do. We have to charge subscribers to access articles because, unlike WebMD, Healthline, or the Mayo Clinic, we don't allow pharmaceutical companies to write or edit our articles. 

You can access this and many other articles by becoming a subscriber.

How Do You Subscribe?

See the following article, which explains what you get with a subscription Subscribe to the Site.

You can be reading this article and many others like it in just a few minutes from now.